eprex การใช้
- The figures indicate that the safety concerns are already hurting Eprex sales.
- Despite the rise, the cases are still rare even in Eprex users.
- Johnson & amp; Johnson makes Eprex at a factory in Puerto Rico.
- Casadevall said she agreed that Eprex should not be taken off the market.
- It also wrote to doctors telling them of the difficulties Eprex was encountering.
- Now subcutaneous injection of Eprex for kidney patients is essentially prohibited in Europe.
- There have been 141 suspected cases of red cell aplasia in Eprex users.
- On Monday, Amgen tried to distance its products from the problems of Eprex.
- Those companies cannot help seeing opportunity in the tarnishing of Eprex's reputation.
- In addition to Eprex, Johnson & amp; Johnson markets anemia drug Procrit.
- In virtually all of them, patients on kidney dialysis had been injected with Eprex.
- Eprex is a worst-case scenario.
- Eprex accounted for dlrs 1.2 billion in sales last year . _ __
- During the conference call, analysts raised concerns about future sales of Eprex and Procrit.
- Eprex and Procrit, both marketed by Johnson & amp; Johnson, also treat anemia.
- During the conference call, analysts raised concerns about future sales of both Eprex and Procrit.
- It is unclear whether the government suspects that manufacturing violations are responsible for the illnesses suffered by Eprex patients.
- Johnson & amp; Johnson, under license from Amgen, sells it under the names Procrit and Eprex.
- Sales of Procrit / Eprex, drugs used to treat anemia in cancer patients, rose by 54 percent.
- Roche's EPO products include Recormon and NeoRecormon, while Johnson & AMP; Johnson markets Eprex and Erypo.
- ตัวอย่างการใช้เพิ่มเติม: 1 2 3